Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wenyang Jieyu formula granule is a Traditional Chinese Medicine (TCM) preparation developed by the Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine. It is formulated based on the "Wenyang Jieyu" (warming yang and relieving depression) therapeutic principle, which is intended to address the TCM pathogenesis of depression in patients with Parkinson's disease. The formula typically consists of a combination of several herbal extracts, such as *Radix Aconiti Lateralis Praeparata* and *Herba Epimedii*, which are processed into a granule form for oral administration. It has been evaluated in Phase 2 clinical trials in China to assess its efficacy and safety in treating depressed Parkinson's disease (DPD) compared to standard pharmacological treatments like venlafaxine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wenyang jieyu formula granule.